Table 1.
Cumulative susceptibility pattern of Pseudomonas spp. to various antimicrobial agents.
| Antimicrobial agent | Codes | Sensitive N (%) |
Intermediate N (%) |
Resistant N (%) |
|---|---|---|---|---|
| Amoxicillin | AML | 50 (14.97) | 39 (11.68) | 245 (73.35) |
| Amoxicillin + clavulanic acid | AMC | 82 (24.55) | 26 (7.78) | 226 (67.66) |
| Piperacillin + tazobactam | TZP | 203 (60.78) | 55 (16.47) | 76 (22.75) |
| Cefoperazone + sulbactam | SCF | 231 (69.16) | 44 (13.17) | 59 (17.66) |
| Cefaclor | CEC | 71 (21.26) | 22 (6.59) | 241 (72.16) |
| Ceftazidime | CAZ | 111 (33.23) | 27 (8.08) | 196 (58.68) |
| Ceftriaxone | CRO | 121 (36.23) | 37 (11.08) | 176 (52.69) |
| Cefepime | FEP | 162 (48.50) | 17 (5.09) | 155 (46.41) |
| Sparfloxacin | SPX | 186 (55.69) | 14 (4.19) | 134 (40.12) |
| Ciprofloxacin | CIP | 168 (50.30) | 19 (5.69) | 147 (44.01) |
| Gatifloxacin | GTX | 149 (44.61) | 84 (25.15) | 101 (30.24) |
| Enoxacin | ENX | 117 (35.03) | 37 (11.08) | 180 (53.89) |
| Moxifloxacin | MXF | 206 (61.68) | 35 (10.48) | 93 (27.84) |
| Erythromycin | E | 64 (19.16) | 22 (6.59) | 248 (74.25) |
| Clarithromycin | CLR | 142 (42.51) | 37 (11.08) | 155 (46.41) |
| Meropenem | MEM | 304 (91.02) | 4 (1.20) | 26 (7.78) |
| Imipenem | IPM | 282 (84.43) | 15 (4.49) | 37 (11.08) |
| Gentamycin | CN | 62 (18.56) | 24 (7.19) | 248 (74.25) |
| Amikacin | AK | 216 (64.67) | 17 (5.09) | 101 (30.24) |
| Doxycycline | DO | 34 (10.18) | 19 (5.69) | 281 (84.13) |